CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 87 enrolled
Drug / intervention
Liposomal Bupivacaine +6 moredrug
Likely dose
Liposomal Bupivacaine 10 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02519023
NCT02519023Phase 4Completed

Transversus Abdominis Plane (TAP) Infiltration vs. Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Assisted Hysterectomy

University of Minnesota·interventional·Posted Aug 10, 2015·Updated Feb 8, 2019

In Brief

A Phase 4 clinical trial evaluating Liposomal Bupivacaine, Bupivacaine, and 5 other interventions for Acute Pain. Completed, enrolled 87 participants across 1 site.

Detailed Summary

Laparoscopic and Robotic assisted hysterectomy is a surgical procedure that is a minimally invasive way in which to remove the uterus, which has less scarring and fewer complications. However, this procedure, much like its open-surgical counterpart, is often associated with significant post-operative pain. To augment this pain there are many different analgesic techniques available to offset pain. Ultrasound-guided transversus abdominis plane (TAP) block is one such procedure involving the injection of a local anesthetic into the plane of the transversus abdominal muscle where the terminal branches of nerves lie. A similar, yet different analgesic approach is that of direct injection of local anesthetic into the incision by the surgeon during or just after surgical procedures. These two approaches have both been proven to decrease post-operative pain in patients for many procedures, but never compared to one another.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 10, 2015
Enrollment StartJul 1, 2016
Primary CompletionMay 1, 2017
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.9 years ago

Interventions

Liposomal Bupivacainedrug

In one arm the TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline. This will then be repeated on the contralateral side.

Bupivacainedrug

Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions. At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions.

Ultrasounddevice

An ultrasound, which is a beam of high frequency sound that allows one to visualize images in the body, will be used to aid investigators to observe the local anesthetic being infiltrated into the plane

Epinephrinedrug

TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine.

acetaminophendrug

all individuals will receive scheduled acetaminophen (1 gram every 6 hours),

ibuprofendrug

all individuals will receive scheduled ibuprofen (800 mg every 8 hours)

Oxycodonedrug

all individuals will receive PRN oxycodone 5-10mg q4h if pain is rated at more than 5 out of 10 on a numerical pain scale.